{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Modified cells and methods of therapy", "item": "https://www.patentleaderboard.com/patent/10406177"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified cells and methods of therapy

Modified cells and methods of therapy

US Patent 10406177 · Granted Sep 10, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

T cell receptors recognizing R175H or Y220C mutation in P532025
Methods of conditioning patients for T cell therapy2025
HLA class II-restricted t cell receptors against RAS with G12R mutation2025
T cell receptors recognizing HLA-A1-restricted MAGE-A32025
Methods of producing T cell populations using hydroxycitric acid and/or a salt t2025
T cell receptors recognizing MHC class II-restricted MAGE-A32025
Anti-KRAS-G12D T cell receptors2025
Methods for culturing cells2025
HLA class II-restricted t cell receptors against mutated RAS2025
Lymphohematopoietic engineering using CAS9 base editors2025
Lymphohematopoietic engineering using CAS9 base editors2025
Human T cell derived from T cell-derived induced pluripotent stem cell and metho2025